ArticleFrontiers in pharmacology2024

Omalizumab in combination with subcutaneous immunotherapy for the treatment of multiple allergies associated with attention-deficit/hyperactivity disorder: a case report and a literature review.

Bo Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.